Alumis (ALMS) Other Non Operating Income (2023 - 2025)
Alumis' (ALMS) quarterly Other Non Operating Income came in at -$183.3 million in Q4 2025, down 2191.83% year-on-year from $8.8 million in Q4 2024, and down 339318.52% on a QoQ basis from -$54000.0 in Q3 2025.
Alumis (ALMS) Other Non Operating Income (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Other Non Operating Income data on file, last reported at -$183.3 million in Q4 2025.
- On a quarterly basis, Other Non Operating Income fell 2191.83% year-over-year to -$183.3 million in Q4 2025; TTM through Dec 2025 was $4.5 million, a 47.85% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, up 37.69% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$183.3 million, down from -$54000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for ALMS reached as high as $187.9 million in Q2 2025 and fell as low as -$183.3 million in Q4 2025.
- Historically, Other Non Operating Income has averaged $1.3 million across 3 years, with a median of -$26000.0 in 2023.
- On a YoY basis, Other Non Operating Income climbed as much as 552767.65% in 2025 and fell as far as 2191.83% in 2025.
- Year by year, Other Non Operating Income stood at -$18000.0 in 2023, then surged by 48777.78% to $8.8 million in 2024, then slumped by 2191.83% to -$183.3 million in 2025.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$183.3 million in Q4 2025, -$54000.0 in Q3 2025, and $187.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alumis | 2.37 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -183.29 Mn |
| Sep 30, 2025 | -54,000.00 |
| Jun 30, 2025 | 187.91 Mn |
| Mar 31, 2025 | -44,000.00 |
| Dec 31, 2024 | 8.76 Mn |
| Sep 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -34,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Sep 30, 2023 | -18,000.00 |
| Jun 30, 2023 | -11,000.00 |